Supplementary Table 2 from Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma

Autor: Andrew X. Zhu, David P. Ryan, Leif W. Ellisen, David P. Schenkein, Sam Agresta, Kimberly S. Straley, Nabeel Bardeesy, Kenneth K. Tanabe, Cristina R. Ferrone, Jennifer Y. Wo, Theodore S. Hong, Supriya K. Saha, Janet E. Murphy, Lawrence S. Blaszkowsky, Jill N. Allen, Jeffrey W. Clark, Eunice L. Kwak, A. John Iafrate, Jason E. Faris, Katharine Yen, Hyeryun Kim, Hua Yang, Hannah M. Liebman, David C. Christiani, Vikram Deshpande, Marek Ancukiewicz, Ronnie T. Poon, Thomas Yau, Lipika Goyal, Darrell R. Borger
Rok vydání: 2023
DOI: 10.1158/1078-0432.22451924.v1
Popis: PDF file - 104KB, Clinical features of IDH1-mutant intrahepatic cholangiocarcinoma patients in the Screening cohort.
Databáze: OpenAIRE